View in EDS

Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells.

Saved in:
Bibliographic Details
Title: Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells.
Authors: Sarthy AV; Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA. aparna.sarthy@abbott.com, Morgan-Lappe SE, Zakula D, Vernetti L, Schurdak M, Packer JC, Anderson MG, Shirasawa S, Sasazuki T, Fesik SW
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2007 Jan; Vol. 6 (1), pp. 269-76.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Print ISSN: 1535-7163 (Print) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 17237286
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sarthy+AV%22">Sarthy AV</searchLink>; Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA. aparna.sarthy@abbott.com<br /><searchLink fieldCode="AU" term="%22Morgan-Lappe+SE%22">Morgan-Lappe SE</searchLink><br /><searchLink fieldCode="AU" term="%22Zakula+D%22">Zakula D</searchLink><br /><searchLink fieldCode="AU" term="%22Vernetti+L%22">Vernetti L</searchLink><br /><searchLink fieldCode="AU" term="%22Schurdak+M%22">Schurdak M</searchLink><br /><searchLink fieldCode="AU" term="%22Packer+JC%22">Packer JC</searchLink><br /><searchLink fieldCode="AU" term="%22Anderson+MG%22">Anderson MG</searchLink><br /><searchLink fieldCode="AU" term="%22Shirasawa+S%22">Shirasawa S</searchLink><br /><searchLink fieldCode="AU" term="%22Sasazuki+T%22">Sasazuki T</searchLink><br /><searchLink fieldCode="AU" term="%22Fesik+SW%22">Fesik SW</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2007 Jan; Vol. 6 (1), pp. 269-76.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1535-7163 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=17237286
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-06-0560
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 269
    Titles:
      – TitleFull: Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sarthy AV
      – PersonEntity:
          Name:
            NameFull: Morgan-Lappe SE
      – PersonEntity:
          Name:
            NameFull: Zakula D
      – PersonEntity:
          Name:
            NameFull: Vernetti L
      – PersonEntity:
          Name:
            NameFull: Schurdak M
      – PersonEntity:
          Name:
            NameFull: Packer JC
      – PersonEntity:
          Name:
            NameFull: Anderson MG
      – PersonEntity:
          Name:
            NameFull: Shirasawa S
      – PersonEntity:
          Name:
            NameFull: Sasazuki T
      – PersonEntity:
          Name:
            NameFull: Fesik SW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2007 Jan
              Type: published
              Y: 2007
          Identifiers:
            – Type: issn-print
              Value: 1535-7163
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1